Universitätsklinikum Heidelberg

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025 (2025) Thill M, Janni W, Albert US, Banys-Paluchowski M, Bartsch R, Bauerfeind I, Bjelic-Radisic V, et al. Journal article, Review article AI-driven simplification of surgical reports in gynecologic oncology: A potential tool for patient education (2025) Riedel M, Meyer B, Kfuri Rubens R, Riedel C, Amann N, Kiechle M, Riedel F Journal article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article Prognostic value of CT-defined coronary sclerosis in COVID-19: Results of a multicenter study based on the Weston score (2025) Bucher AM, Frodl E, Ehrengut C, Müller L, Emrich T, Kloeckner R, Sieren M, et al. Journal article European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) guideline on stroke due to spontaneous intracerebral haemorrhage (2025) Steiner T, Purrucker JC, Aguiar de Sousa D, Apostolaki-Hansson T, Beck J, Christensen H, Cordonnier C, et al. Journal article Androgenrezeptor-gerichtete Therapien – klinisch relevante Interaktionen vermeiden (2025) Lipp HP, Von Amsberg G, Merseburger AS, Rausch S, Schöning T, Klier J, Goebell P Journal article, Review article S3-Leitlinie Klinische Ernährung und Hydrierung im Alter (2025) Volkert D, Bauer J, Benzinger P, Eglseer D, Frühwald T, Gehrke I, Kiesswetter E, et al. Journal article Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial. (2025) Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, et al. Journal article Guideline-recommended basic parameter adherence in neurocritical care stroke patients: Observational multicenter individual participant data analysis. (2025) Mrochen A, Alhaj Omar O, Pelz JO, Michalski D, Neugebauer H, Lehrieder D, Knier B, et al. Journal article Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis (2025) Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, Weinbergerová B, Šrámek J, Valka J, et al. Journal article